Resonance Health Ltd has released a press release.
Execution of Licence Agreement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Resonance Health
- Resonance Health Files New Provisional Patent
- Market Update
- Controlled Placement Facility
- Licencee & Royalty Agreement with 3DR Laboratories
- Resonance Health Partners with Siemens Healthineers
Later from Resonance Health
- New Pulmonary Embolism AI Solution Developed
- HepaFat-AI gains US FDA clearance
- HepaFat-AI Incorporated into Blackford Analysis
- HepaFat-AI Receives TGA Approval
- HepaFat-AI receives CE Marking
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health